Wei He
Impact in
- Pharmaceutical Science top 0.1%
- Advanced Drug Delivery Systems
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Drug Solubulity and Delivery Systems 29
- Advanced Drug Delivery Systems 23
- Biomaterials 60
- Nanoparticle-Based Drug Delivery 58
- Co-authors
- Lifang YinMoungi G. BawendiOu ChenJi‐Xin ChengPhilip S. LowWei WuZhongjian ChenImran Shair Mohammad
- Journals
- International Journal of Pharmaceutics (22 papers)Acta Pharmaceutica Sinica B (14 papers)Chinese Chemical Letters (10 papers)AAPS PharmSciTech (7 papers)Journal of Controlled Release (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Wei He
234 papers receiving 11.1k citations
Hit Papers
Peers
Comparison fields: 5 of 169
- Pharmaceutical Science 1.2k
- Biomaterials 2.3k
- Molecular Biology 4.5k
- Biomedical Engineering 2.4k
- Materials Chemistry 2.4k
Countries citing papers authored by Wei He
This map shows the geographic impact of Wei He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei He more than expected).
Fields of papers citing papers by Wei He
This network shows the impact of papers produced by Wei He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei He. The network helps show where Wei He may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 15 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 15 | |
| 10 | 2023 | 5 | |
| 11 | 2023 | 71 | |
| 12 | 2023 | 40 | |
| 13 | 2023 | 10 | |
| 14 | 2023 | 13 | |
| 15 | 2022 | 38 | |
| 16 | 2021 | 4 | |
| 17 | 2020 | 39 | |
| 18 | Morusin Ameliorates IL-1β-Induced Chondrocyte Inflammation and Osteoarthritis via NF-κB Signal Pathway | 2020 | 4 |
| 19 | 2020 | 47 | |
| 20 | Determination of cocaine in rat's serum by high performance liquid chromatography | 2002 | 0 |
About Wei He
Wei He is a scholar working on Pharmaceutical Science, Biomaterials, Animal Science and Zoology, Molecular Biology and Cancer Research, having authored 248 papers that have together received 11.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (58 papers), RNA Interference and Gene Delivery (31 papers), Drug Solubulity and Delivery Systems (29 papers), Advanced Drug Delivery Systems (23 papers), Nanoplatforms for cancer theranostics (19 papers), Advanced biosensing and bioanalysis techniques (17 papers), Lipid Membrane Structure and Behavior (12 papers) and Nanocluster Synthesis and Applications (8 papers). The work is most often cited by research in Pharmaceutical Science (1.2k citations), Biomaterials (2.3k citations), Molecular Biology (4.5k citations), Biomedical Engineering (2.4k citations) and Materials Chemistry (2.4k citations). Wei He has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Lifang Yin, Moungi G. Bawendi, Ou Chen, Ji‐Xin Cheng, Philip S. Low, Wei Wu, Zhongjian Chen, Imran Shair Mohammad, Alexander Wei and Joan Massagué. Their work appears in journals such as International Journal of Pharmaceutics, Acta Pharmaceutica Sinica B, Chinese Chemical Letters, AAPS PharmSciTech and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.